Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic… · FederalPipeline
Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic…
Presolicitation from National Institutes of Health, solicitation 75N98026Q00392. Responses due Jun 3, 2026. NAICS 622110, No Set aside used. Listed on SAM.gov.